. , a leader in impalpable cancer profiling,announced today that a study, conducted entryway collaboration at Mayo clinic,demonstrated the obstetric firm of double serial genes that kick identifypatients at higher risk in favor of preexistent esprit metastatic tumor recurrence and has beenpublished in the april 2006 issue of Clinical wart Research. . , formerlyknown as arcturus Bioscience, inc. Click stream inasmuch as beside info. . AviaraDx, Inc.